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Abstract 
During a randomized placebo-controlled trial of chemoprophylaxis against Plasmodium falciparum malar- 
ia and iron supplementation, in infants living under conditions of intense transmission, all samples of I? 
fazciparum obtained from children aged 5 and 8 months were genotyped by polymerase chain reaction- 
restriction fragment length polymorphism analysis for the msp2 locus. One hundred and six blood sam- 
ples were analysed for the number of concurrent infections (multiplicity), and the allelic family of each 
msp2 genotype was determined. Mean multiplicity of infection was, overall, 2.76 infections/child, and it 
was significantly reduced in infants receiving chemoprophylaxis. This finding might help to explain the 
rebound effect in morbidity observed after prophylaxis was ended. Iron supplementation did not affect 
multiplicity of infection. In infants receiving placebo only, or placebo and iron supplementation, a signif- 
icant positive association was observed between the number of infections and parasite densities 
(Spearman’s p=O.25, P-0.047). This association was lost in the group receiving chemoprophylaxis alone, 
or in combination with iron. This study showed a significant association of FC27-like msp2 alleles with 
prospective risk of clinical malaria in children (relative risk=l.487, eO.013). Such an association was 
also found for the present risk of clinical malaria in infants receiving prophylaxis (odds ratio=3.84, 
P=O.O26), which might imply that chemoprophylaxis may impair the development of premunition. 
Keywords: malaria, PZasmodium falciparum, multiple infection, genotypes, msp2 gene, DeltaprimTM, dapsone, 
pyrimetbamine, iron supplementation, premunition,Tanzania 
Introduction 
Anaemia is the major cause of severe malaria morbid- 
ity in Tanzanian children living under conditions of 
high malaria transmission (KITUA et al., 1996; MENEN- 
DEZ et al., 1997). Chemoprophylaxis has been recom- 
mended to reduce malaria morbidity in infants, and iron 
supplementation has been recommended to prevent the 
adverse effects of iron deficiencies (AMERICAN ASSOCI- 
ATION, 1978). However, both recommendations have 
elicited substantial controversy. Prophylaxis for young 
children in holoendemic areas has been questioned 
(GREENWOOD et al., 1995), because of its effect on the 
development of semi-immunity that gradually builds up 
either because of frequent infections with antigenically 
distinct Plasmodium falciparum parasites (GUPTA et al., 
1994) or because of the chronicity of infections (SMITH 
et al., 1999b). It has been speculated that long-term 
chemoprophylaxis, similarly to exposure-reducing 
interventions, might interfere with the acquisition of 
infections or their chronicity, and thus impair the 
development of naturally acquired semi-immunity. 
Furthermore, removal of such interventions would 
result in a rebound effect, shifting the malaria-attribut- 
able morbidity and mortality pattern to older ages 
(SNOW&MARSH,~~~~). 
With respect to iron supplementation, controversial 
evidence exists (OPPENHEIMER, 1989; HERSHKO, 
1996). Several studies showed decreased susceptibility 
to malaria in iron-deficient or anaemic children (MUR- 
RAY et al., 1978; OPPENHEIMER et al., 1986), whereas 
others did not find such an association (BATES et al., 
1987; MENENDEZ et al., 1994). Most microorganisms 
are heavily dependent on external iron provision 
(WEINBERG, 1978), and reduction in available iron may 
also put parasites at a disadvantage. Therefore, one 
might speculate that a sufficient supply of iron would 
enable parasite infections to grow to higher densities. 
This could increase host susceptibility or morbidity, or 
favour multiple infections, with unknown consequenc- 
es. 
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A recent randomized placebo-controlled trial of che- 
moprophylaxis and iron supplementation in infants liv- 
ing in Ifakara, Tanzania, an area holoendemic for 
malaria, clearly showed the beneficial effects of both 
chemoprophylaxis and iron supplementation in chil- 
dren less than one year of age (MENENDEZ et al., 1997). 
In this study, children receiving chemoprophylaxis had 
a reduced risk of severe anaemia and of clinical malaria 
episodes. Iron supplementation significantly reduced 
the number of severely anaemic children, but did not 
increase susceptibility to malaria. Within this study we 
investigated whether chemoprophylaxis or iron supple- 
mentation would affect multiplicity of infections, and 
whether the development of premunition would be af- 
fected. We also tested whether genotypes of different 
msp2 allelic families were differentially affected by either 
of these interventions. 
Material and Methods 
The study took place in Ifakara town in south-eastern 
Tanzania, an area holoendemic for malaria. A detailed 
description of the trial has been given by MENENDEZ et 
al. (1997). Briefly, 832 infants were enrolled at birth af- 
ter informed consent of their parents and randomly al- 
located to one of 4 groups: (i) 204 children received oral 
iron supplementation (2 mgikgld) plus weekly placebo 
syrup (group II’): (ii) 208 children received 25 mL Del- 
taprimTM syrup (pyrimethamine 3.125 mg+dapsone 25 
mgi25 mL, Wellcome, South Africa) weekly and daily 
placebo syrup (group DP); (iii) 213 children received 
weekly DeltaprimTM and daily iron supplementation 
(group DI); and (iv) 207 children received daily and 
weekly placebo syrup (group PI’). All children were fol- 
lowed by cross-sectional surveys conducted at 2, 5, 8 
and 12 months of age, and clinical episodes of all chil- 
dren were recorded by a passive case detection system 
at the local hospital. A clinical malaria episode was de- 
fined as axillary temperature >37.4”C and I? falciparum 
parasitaemia, with no density cut-off level. During the 
cross-sectional surveys, and at each visit with presump- 
tive malaria, a linger-prick blood sample was collected 
for microscopical assessment and subsequent polymer- 
ase chain reaction-restriction fragment length polymor- 
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phism (PCR-RFLP) analysis. Haematological and 
malariological indices and sickle cell status were deter- 
mined as described by MENENDEZ et al. (1997). 
The genotyping study was carried out on all samples 
obtained during the cross-sectional surveys from chil- 
dren aged 5 and 8 months who had been found to be 
positive for I? falciparum by microscopy. Deoxyribonu- 
cleic acid (DNA) was prepared and used for PCR am- 
plification of the msp2 locus as described by FELGER et 
al. (1999a). The number of concurrent infections and 
the individual genotypes of msp2 were determined. 
significant decrease in multiplicity between the surveys 
at months 5 and 8 was observed, which was due to a de- 
crease in numbers of 3D7-alleles (Table 1). The age ef- 
fect on mean multiplicity was not significant when 
tested for the individual intervention groups, most 
probably due to the small numbers in each group. How- 
ever, mean multiplicity was lower at month 8 than at 
month 5 in all intervention groups, and data for both 
surveys were combined for the further analysis. 
The total number of multiple infections and the 
number of infections belonging to either of the 2 allelic 
families (FC27-like, 3D7-like) were analysed with re- 
spect to survey (age), intervention group, present and 
prospective risk of clinical malaria, parasite density, 
packed cell volume (PCV), and sickle cell status. 
Data analysis was carried out with STATA~~ ~5.0 sta- 
tistical software (STATA Corp., Texas, USA). The Wil- 
coxon test was applied to compare the average number 
of total, FC27-like and 3D7-like infections between the 
intervention groups and between the surveys. Spear- 
man’s correlation coefficients were calculated to assess 
associations between multiplicity of infection and para- 
site densities or PCV levels. 
Mean multiplicity in the different intervention groups 
is shown in Table 2. Since no significant difference was 
observed between the IP and PP groups, or between the 
DP and DI groups, we combined all data for further 
analysis into 2 groups, IPPP and DI/DP. Mean multi- 
plicity of infections was significantly reduced in children 
receiving chemoprophylaxis (DI/DP) compared with 
children in the IPPP group (Table 2). Except for the 
age-dependent reduction of mean multiplicity of 3D7- 
like infections, no further specific effect on the distribu- 
tion of genotypes of either allelic family between the dif- 
ferent intervention groups was found. 
Logistic regression models were fitted to assess the 
significance of the relationship between the number of 
infections and the current risk of clinical malaria at the 
cross-sectional survey or during 15 d afterwards. Pois- 
son regression models were also fitted to evaluate the ef- 
fect of the total multiplicity or of the multiplicity of 
FC27-like and 3D7-like infections on the subsequent 
incidence of first clinical malaria episodes during the 
first year of life and after the fifth month or eighth 
month, depending on the survey. The time at risk was 
calculated for each child as the period between the sur- 
vey and the date of the first or only clinical malaria epi- 
sode, or the date of withdrawal, or the end of its first 
year of life. If a child had a clinical episode at the time 
of the cross-sectional survey or during the following 2 
weeks, the time at risk was considered to begin 28 d af- 
ter the survey. 
Parasite densities in the IP/PP group were significant- 
ly positively correlated with the number of concurrent 
infections (Table 3). However, this correlation was en- 
tirely due to a positive correlation of parasite density 
with the number of concurrent infections of the FC27- 
type, and 3D7-like infections showed no correlation. 
This trend was also observed in the DI/DP group, but 
did not reach significance (Table 3). 
Results 
In the cross-sectional survey at month 5, 52 samples 
were found to be parasite-positive by microscopy, and 
there were 60 such samples in the survey at month 8. A 
PCR product was obtained from 49 month 5 samples 
and from 57 month 8 samples. The mean number of 
concurrent total, FC27-like and 3D7-like infections in 
the sample from these 2 surveys is shown in Table 1. A 
Children with febrile episodes and parasitaemia in 
both groups (IPPP, n=17 and DI/DP, n=5) showed 
non-significant higher multiplicity than asymptomatic 
children (~47 and ~37, respectively). Logistic regres- 
sion models suggested a trend that the risk of clinical 
malaria might increase with increasing multiplicity 
[likelihood ratio test (LRT): x12=3.412, P=O+O65]. 
This effect was found to be higher in the IPiPP group 
(LRT: x12=3*51, P=O*O61) but there was no statistical- 
ly significant interaction between the intervention group 
and the number of infections (Table 4). This risk was 
mainly determined by the number of FC27-like infec- 
tions (LRT: x12=3.64, -0.056). This model showed a 
trend for higher risk of clinical malaria in the DVDP 
group (LRT: x12=3.51, P=O.O61), and also suggested a 
possible interaction between the intervention group and 
the number of FC27-like infections (LRT: x12=2.287, 
P=O. 13). Separate logistic regression models within the 
2 groups showed that for every acquired FC27-like in- 
fection the risk of clinical malaria in the DI/DP group 
increased 3.84 times [95% confidence interval (CI) 
1*07-13.85, *0*026], whereas it increased only 1.38 
Table 1. Average number of concurrent Plasmodium falciparum infections in all intervention groups at 
both surveys 
No. of Multiplicity of genotypesa 
Survey subjects All FC27-like 3D7-like 
5 months 49 3.12(1.32) 0.86 (0.94) 2.25(1.16) 
8 months 57 2.44(1.12) 0.72 (0.80) 1.72(1.10) 
Wilcoxon’s Z - 2.55 0.600 2.790 
P - 0.011 0.548 0.005 
aMean (SD in parentheses) 
Table 2. Number of all Plasmodium faln$arum infections according to intervention group 
Intervention No. PCRa-positive Multiplicityb Wilcoxon’s Z P 
DeltaprimrM/iron 
DeltaprimTM/placebo 
Iron/placebo 
Placebo/placebo 
Both groups with DeltaprimTM 
Both groups without DeltaprimTM 
19 2.26(1.10) 0.771 0.441 
2*57(1*31) 
2I 3.04(1.43) 0.056 0.955 
2.92(1.11) 
E 2.43(1.21) 2.19 0.029 
64 2.97(1.25) 
G’olymerase chain reaction. 
bMean (SD in parentheses). 
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Table 3. Spearman’s correlation of Plasmodium fahparum parasite densities and number of concurrent 
infections 
Placebo+placebo/iron+placebo group (n=64) DeltaprimTM+placebo/DeltaprimTM+iron group (n=42) 
All FC27-like 3D7-like All FC27-like 3D7-like 
genotypes genotypes genotypes genotypes genotypes genotypes 
Spearman’s p 0.250 0.295 0.038 0.134 0.262 -0.014 
P 0.047 0.019 0.76 0.39 0.09 0.93 
Table 4. Logistic models to assess the association of total number of Plasmodium falciparum infections 
with the present risk of clinical malaria 
Outcome variable Explanatory variable Odds ratio 95% Confidence interval Pa 
Risk of clinical malariab No. of infections 
In IP/PP groupc+ 1.486 0.934-2.365 0.086 
In DVDP group+ 1.326 0.623-2.825 0.467 
No. of FC27-like infections 
In IP/PP groupCJ 1.355 0.739-2.484 0.328 
In DUDP groupdaf 3.84 1.065-13.85 0.026 
No. of 3D7-like infections 
In IP/PP groupcae 1.292 0.806-2.07 1 0.286 
In DIiDP groupd+ 0.685 0.264-1.782 0.419 
aLikelihood ratio test (LRT). 
Uinical malaria: l?fulciparum parasitaemia plus temperature >37,4”C at the cross-sectional survey or 15 d later. 
cIron+placebo/placebo+placebo. 
dDeltaprimTM+iron/DeltaprimTM+placebo. 
eNo interaction between intervention group and numbers of infections. 
flnteraction between intervention group and numbers of FC27-like infections of borderline significance (LRT: x2=1.29, P-0.13). 
Table 5. Poisson models to assess the association of multiple Plasmodium fakiparum infections with the 
prospective risk of first clinical malaria episodes occurring in the subsequent observation period between 
the cross-sectional surveys and the first year of life 
Outcome variable Explanatory variable Relative risk 95% Confidence interval Pa 
Incidence rate of prospective Nos. of concurrent infections 
first clinical malaria episodeb All 1.235 0.924-l .65 1 0.163 
FC27-like 1.847 1.167-2.923 0.013 
3D7-like 0.953 0.659-1.377 0.796 
aLikelihood ratio test. Interactions between intervention groups and number of infections nof significant 
bclinical malaria: Pfalciparum parasitaemia plus temperature >37.4”C. 
times in the IP/PP group (95% CI 0.66-2.92, -0.403) 
(Table 4). The models showed no evidence of an asso- 
ciation between the number of 3D7-like infections and 
the risk of clinical malaria in either intervention group. 
We also wanted to assess whether the number of con- 
current infections (all, FC27-like, or 3D7-like) would 
determine the subsequent period to the first clinical ma- 
laria episode. Poisson regression showed no evidence 
that the total number of infections had an effect on the 
incidence rate of first clinical malaria episodes after the 
cross-sectional survey (Table 5). However, numbers of 
concurrent FC27-like infections significantly deter- 
mined the incidence rate of first episodes, but there was 
no statistically significant difference in the incidence 
rate between the intervention groups. 3D7-like infec- 
tions did not determine the incidence rate of first clini- 
cal episodes in either group (Table 5). 
Because of reduced anaemia in both the iron supple- 
mentation group and the DeltaprimTM group (MENEN- 
DEZ et al., 1997), we tested whether anaemia was also 
determined by the number of concurrent infections. 
Spearman’s correlations between PCV values and num- 
bers of concurrent infections for each intervention 
group showed that neither multiplicity nor numbers of 
genotypes belonging to the 2 allelic families affected the 
PCV values (data not shown). 
Within the tested samples, 8 sickle cell gene carriers 
were detected. Globin genotypes showed no significant 
effect on numbers of concurrent infections (Wilcoxon’s 
Z=1.369, P=O.171), although there was a reduction in 
FC27-like infections in the 8 carriers of the sickle cell 
trait (mean number of infections 0.375) compared with 
96 children with normal or fetal haemoglobin (mean 
number 0.833). 
Discussion 
The present study was intended to elucidate the effect 
of interventions on the infecting P. falciparum popula- 
tion. We tested whether naturally-occurring mecha- 
nisms leading to the development of semi-immunity or 
premunition might be affected by these interventions. 
Genotyping of parasites and enumeration of concurrent 
infections have proven to be powerful techniques to add 
to our understanding of the dynamics of infections and 
the development from a non-immune infant to a semi- 
immune child (AL-YAMAN et al., 1997; BECK et al., 
1997; FELGER et al., 1999b; SMITH et al., 1999a, 
1999b). Thus, the finding of a significant reduction of 
multiplicity in children receiving DeltaprimTM prophy- 
laxis may partly help to explain the rebound effect in 
morbidity seen in the observation period after the end of 
prophylactic treatment (MENENDEZ et al., 1997). Re- 
duction of blood-stage infections may reduce the 
number of concurrent infections and thus might impair 
the development of premunition. In another study, in 
which no intervention was made, we have shown that 
infants aged 5-8 months already harbour a mean of 2.7 
infections (FELGER et al, 1999b). This is in agreement 
with the observed multiplicity in children receiving no 
chemoprophylaxis, and provides evidence that iron sup- 
plementation does not support the establishment of a 
higher number of infections. In the same study in in- 
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fants, little age-dependency of multiplicity was observed 
during the first year of life, though there was a small in- 
crease at the end of the first vear (SMITH et al., 1999a). 
Thus the reason for the obseked reduction in multiplic- 
ity in blood samples from the cross-sectional surveys 
conducted at months 5 and 8 in all groups remains un- 
clear. One could speculate that the reduction might 
have been due to the frequent hospital attendance of all 
the children in this study, which could have reduced the 
malaria prevalence because they were more frequently 
under medical care. Whatever effect was responsible for 
this reduction, it is interesting that it seemed to act only 
on 3D7-like infections, while FC27-like infections were 
not affected. 
A further important finding of this study is that para- 
site densities were positively correlated with the number 
of concurrent infections and in particular with infec- 
tions due to parasites with the FC27-type msp2 gene. 
This trend was also observed in our previous analysis of 
multiplicity of infections during the SPf66 malaria vac- 
cine trial (BECK et al., 1997) and in a study in Papua 
New Guinea by ENGELBRECHT et al. (1995). In this 
context it is al& noteworthy that infants infected with 
FC27-alleles had, on average, significantly higher para- 
site densities in all intervention groups than infants with 
infections without FC27-like alleles (Wilcoxon’s 
Z=-2.63. P=O.O09’,. There was no statisticallv sienifi- 
I 
cant difference in the average parasite densitiesbenveen 
infants with or without 3D7-like alleles (Wilcoxon’s 
Z=O.37, -0.715). However, such an effect of FC27- 
like infections on parasite density was not found in in- 
fants from Idete (FELGER et aZ., 1999b). It is interesting 
to observe that the correlation between density and 
numbers of all genotypes was lost in children receiving 
prophylaxis, and that the correlation with numbers of 
FC27-like genotypes was smaller than in children with- 
out prophylaxis. Such a loss of correlation implies that 
DeltaprimTM prophylaxis controls or reduces high para- 
site densities, which are mostly reached when a child is 
infected with parasites of the FC27-like genotype. This 
effect may also be one of the mechanisms leading to the 
observed reduction in morbidity (MENENDEZ et al., 
1997). 
The observation of an association between increased 
risk of present clinical malaria, or the incidence rate of 
first episodes, and numbers of FC27-like infections is in 
concordance with findings from Papua New Guinea 
(ENGELBRECHT et al., 1995), but no such association 
could be observed in a recent study by Km and col- 
leagues (1998), who compared severe malaria cases 
with mild malaria cases in Gabon. The association be- 
tween the higher risk for current clinical episodes and 
FC27-like infections in infants receiving prophylaxis 
might hint that the development of premunition is im- 
paired in these children. Nevertheless, the overall re- 
duction in multiplicity, both of FC27-like and 3D7-like 
infections, would have contributed to the immediate 
beneficial effect of chemoprophylaxis. 
The lack of an association between 3D7-like infec- 
tions and risk of clinical malaria, however, is in contrast 
to the situation in infants from Idete (FELGER et al., 
1999b). Because we used only samples with positive 
PCR results in the analysis, we cannot determine 
whether the increased risk of clinical malaria with in- 
creasing numbers of concurrent FC27-like infections 
was indeed an increase, or whether children with 3D7- 
like infections were actually protected against clinical 
malaria, as was observed by AL-YAMAN and colleagues 
(1997) in a study comparing infected and uninfected 
children in Papua New Guinea. Selecting only samples 
positive for I? falciparum for this analysis may have in- 
troduced a bias. Indeed, Kaplan-Meyer survival curves 
indicated that the selected children differed from the to- 
tal sample in the median time to their first clinical epi- 
sode (P fazciparum-positive samples, median time 115 
d, 95% CI 71-398; l? fulciparum-negative samples, me- 
dian time 379 d, 95C 354-437; log rank test, ~12~16.9, 
P~0~0001). 
In conclusion, we were able to show in this study that 
iron supplementation did not increase or affect the mul- 
tiplicity of infection. Furthermore, it did not support in- 
creased growth of certain genotypes compared with the 
other intervention groups. Thus the only effect of iron- 
supplementation was the reduction of anaemia, which is 
clearly beneficial. We also showed that chemoprophy- 
laxis reduced multiplicity in the infections occurring in 
infants. There is some evidence that this reduction 
might interfere with the development of premunition. 
Other studies have suggested that semi-immunity might 
be acquired by frequent infections stimulating respons- 
es which will control parasite growth but will not elimi- 
nate infection (SIWTH et al., 1999b). Therefore, by 
preventing multiple infections from becoming estab- 
lished, chemoprophylaxis might reduce the acquisition 
of premunition. On the other hand, DeltaprimTM proph- 
ylaxis did reduce morbidity in these infants in their first 
months. There was subsequently a rebound effect, but 
the actual clinical episodes may not have been as severe 
for older children as they would have been for infants 
(MOLINEAUX, 1997). 
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